Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 5
2016 2
2017 4
2018 9
2019 9
2020 10
2021 8
2022 7
2023 8
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).
Ruamviboonsuk P, Ng DSC, Chaikitmongkol V, Chang A, Chen SJ, Chen Y, Cheung CMG, Gomi F, Guymer R, Kim JE, Koh A, Kokame GT, Lai CC, Lai TYY, Lee WK, Ogura Y, Sadda S, Teo KYC, Wong TY, Yanagi Y, Lam DSC. Ruamviboonsuk P, et al. Among authors: chaikitmongkol v. Asia Pac J Ophthalmol (Phila). 2025 Jan-Feb;14(1):100144. doi: 10.1016/j.apjo.2025.100144. Epub 2025 Jan 15. Asia Pac J Ophthalmol (Phila). 2025. PMID: 39824255 Free article.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Authors' Reply.
Chaikitmongkol V, Leeungurasatien T, Sengupta S. Chaikitmongkol V, et al. Asia Pac J Ophthalmol (Phila). 2015 Sep-Oct;4(5):316. doi: 10.1097/APO.0000000000000141. Asia Pac J Ophthalmol (Phila). 2015. PMID: 26397211 Free article. No abstract available.
Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice.
Guymer R, Bailey C, Chaikitmongkol V, Chakravarthy U, Chaudhary V, Finger RP, Gallego-Pinazo R, Chuan AKH, Ishida S, Lövestam-Adrian M, Parravano M, Luna Pinto JD, Schmitz-Valckenberg S, Sheth V, Souied EH, Chi GC, Gilberg F, Glittenberg C, Scheidl S, Bengus M. Guymer R, et al. Among authors: chaikitmongkol v. Ophthalmol Sci. 2023 Dec 3;4(3):100442. doi: 10.1016/j.xops.2023.100442. eCollection 2024 May-Jun. Ophthalmol Sci. 2023. PMID: 38304609 Free PMC article.
Idiopathic Epiretinal Membranes: Visual Outcomes and Prognostic Factors.
Kunavisarut P, Supawongwattana M, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Pathanapitoon K, Rothova A. Kunavisarut P, et al. Among authors: chaikitmongkol v. Turk J Ophthalmol. 2022 Apr 28;52(2):109-118. doi: 10.4274/tjo.galenos.2021.09258. Turk J Ophthalmol. 2022. PMID: 35481732 Free PMC article.
66 results